Rickettsia conorii infections (mediterranean spotted fever, israeli spotted fever, Indian tick typhus, astrakhan fever)

Rickettsial Diseases

Volumn , Issue , 2007, Pages 125-138

  Rovery, Clarisse ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84966403726     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (121)

1. Conor A, Bruch A. Une fièvre éruptive observée en Tunisie. Bull Soc Pathol Exot Filial 1910; 8:492-496.
2. Olmer D. Sur une infection épidémique, avec exanthème de nature indéterminée. Mars Med 1925; 22:1291-1293.
3. Brumpt E. Longévité du virus de la fièvre boutonneuse (Rickettsia conorii n. sp.) chez la tique Rhipicephalus sanguineus. C R Soc Biol 1932; 110:1119.
4. Woese CR. Bacterial evolution. Microbiol Rev 1987; 51:222-270.
5. Stackebrandt E, Frederiksen W, Garrity GM, et al. Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. Int J Syst Evol Microbiol 2002; 52:1043-1047.
6. Vandamme P, Pot B, Gillis M, De Vos P, Kersters K, Swings J. Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol Rev 1996; 60(2):407-438.
7. Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol 2005; 5:1-11.
8. Parola P, Paddock C, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 2005; 18(4):719-756.
9. Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 2005; 353(6):587-594.
10. Ogata H, Audic S, Renesto-Audiffren P, et al. Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 2001; 293(5537):2093-2098.
11. Ogata H, Audic S, Abergel C, Fournier PE, Claverie JM. Protein coding palindromes are a unique but recurrent feature in Rickettsia. Genome Res 2002; 12(5):808-816.
12. Renesto P, Ogata H, Audic S, Claverie JM, Raoult D. Some lessons from Rickettsia genomics. FEMS Microbiol Lett 2005; 29:99-117.
13. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997; 10(4):694-719.
14. Tonna I, Mallia AC, Piscopo T, Cuschieri P, Fenollar F, Raoult D. Characterisation of rickettsial diseases in a hospital-based population in Malta. J Infect 2006; 53:394-402.
15. Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R. Mediterranean spotted fever: a review of fifteen cases. J Dermatol 2006; 2:103-107.
16. Kuloglu F, Rolain JM, Fournier PE, Akata F, Tugrul M, Raoult D. First isolation of Rickettsia conorii from humans in the Trakya (European) region of Turkey. Eur J Clin Microbiol Infect Dis 2004; 23(8):609-614.
17. Psaroulaki A, Loukaidis F, Hadjichristodoulou C, Tselentis Y. Detection and identification of the aetiological agent of Mediterranean spotted fever (MSF) in two genera of ticks in Cyprus. Trans R Soc Trop Med Hyg 1999; 93(6):597-598.
18. Arnez M, Luznik-Bufon T, Avsic-Zupanc T, et al. Causes of febrile illnesses after a tick bite in Slovenian children. Pediatr Infect Dis J 2003; 22(12):1078-1083.
19. Sardelic S, Fournier PE, Punda Polic V, et al. First isolation of Rickettsia conorii from human blood in Croatia. Croat Med J 2003; 44(5):630-634.
20. Psaroulaki A, Spyridaki I, Ioannidis A, Babalis T, Gikas A, Tselentis Y. First isolation and identification of Rickettsia conorii from ticks collected in the region of Fokida in Central Greece. J Clin Microbiol 2003; 41(7):3317-3319.
21. Christova I, Van De PJ, Yazar S, Velo E, Schouls L. Identification of Borrelia burgdorferi sensu lato, Anaplasma and Ehrlichia species, and spotted fever group Rickettsiae in ticks from Southeastern Europe. Eur J Clin Microbiol Infect Dis 2003; 22(9):535-542.
22. Giammanco G, Vitale G, Mansueto S, Capra G, Pia Caleca M, Ammatuna P. Presence of Rickettsia conorii subsp. israelensis, the causative agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retrospective study. J Clin Microbiol 2005; 43(12):6027-6031.
23. Bacellar F, De Sousa R, Santos A, Santos-Silva M, Parola P. Boutonneuse fever in Portugal: 1995-2000. Data of a state laboratory. Eur J Epidemiol 2003; 18:275-277.
24. De Sousa R, Nobrega SD, Bacellar F, Torgal J. Mediterranean spotted fever in Portugal-risk factors for fatal outcome in 105 hospitalized patients. Rickettsiology: Present and Future Directions 2003; 990:285-294.
25. De Sousa R, Bacellar F. Morbi-mortalidade por R. conorii em Portugal. Rev Bras Parasitol Vet 2004; 13(suppl 1):180-183.
26. Lopez Pares P, Munoz Espin T, Espejo Arenas E, Font Creus B, Segura Porta F, Martinez Vila I, et al. Mediterranean spotted fever in childhood: prospective study of 130 cases. An Esp Pediatr 1988; 28(4):293-296.
27. Turabian JL, de Lorenzo-Caceres A, Mateo S, Moreiras JL, Marcos F, Tellez A. Prospective studies on 73 cases of boutonneuse fever: validity of the clinico-epidemiological diagnosis and serology with respect to Proteus. Rev Clin Esp 1987; 181(6):300-304.
28. Tinelli M, Maccabruni A, Michelone G, Zambelli A. Mediterranean spotted fever in Lombardy: an epidemiological, clinical and laboratory study of 76 cases in the years 1977-1986. Eur J Epidemiol 1989; 5:516-520.
29. Folghera S, Fiorentini S, Martinelli F, et al. Development of a flow cytometric assay for the detection and measurement of neutralizing antibodies against human immunodeficiency virus. New Microbiol 1994; 17(1):21-28.
30. Raoult D, Lepeu G, de Micco P, et al. Recrudescence de la fièvre boutonneuse meditarraneenne dans le sud de la France. Mediterr Med 1984; 3:102-103.
31. Segura-Porta F, Font-Creus B, Espejo-Arenas E, Bella-Cueto F. New trends in Mediterranean spotted fever. Eur J Epidemiol 1989; 5:438-443.
32. Espejo-Arenas E, Font-Creus B, Bella-Cueto F, Segura-Porta F. Climatic factors in resurgence of Mediterranean spotted fever [letter]. Lancet 1986; 1:1333.
33. Raoult D, Tissot-Dupont H, Caraco P, Brouqui P, Drancourt M, Charrel C. Mediterranean spotted fever in Marseille: descriptive epidemiology and the influence climatic factors. Eur J Epidemiol 1992; 8:192-197.
34. Lambert M, Dugernier T, Bigaignon G, Rahier J, Piot P. Mediterranean spotted fever in Belgium [letter]. Lancet 1984; 2:1038.
35. Peter O, Burgdorfer W, Aeschlimann A, Chatelanat P. Rickettsia conorii isolated from Rhipicephalus sanguineus introduced into Switzerland on a pet dog. Z Parasitenkd 1984; 70:265-270.
36. Senneville E, Ajana F, Lecocq P, Chidiac C, Mouton Y. Rickettsia conorii isolated from ticks introduced to Northern France by a dog. Lancet 1991; 337:676.
37. Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 2001; 32(6):897-928.
38. Rolain JM, Jensenius M, Raoult D. Rickettsial infections-a threat to travellers? Curr Opin Infect Dis 2004; 17(5):433-437.
39. Jensenius M, Fournier PE, Raoult D. Rickettsioses and the international traveler. Clin Infect Dis 2004; 39(10):1493-1499.
40. Harris RL, Kaplan SL, Bradshaw MW, Williams TW Jr. Boutonneuse fever in American travelers. J Infect Dis 1986; 153(1):126-128.
41. McDonald JC, MacLean JD, McDade JE. Imported rickettsial disease: clinical and epidemiologic features. Am J Med 1988; 85:799-805.
42. Rutherford JS, Macaluso KR, Smith N, et al. Fatal spotted fever rickettsiosis, Kenya. Emerg Infect Dis 2004; 10(5):910-913.
43. Nur YA, Groen J, Yusuf MA, Osterhaus AD. IgM antibodies in hospitalized children with febrile illness during an inter-epidemic period of measles, in Somalia. J Clin Virol 1999; 12(1):21-25.
44. Kelly PJ, Mason PR, Raoult D. Spotted fever group rickettsiae in southern Africa-a review and current concepts. Cent Afr Med J 1998; 44(4):111-118.
45. Ekala MT, Gresenguet G, Belec L. Seroprevalence of rickettsial infections of the Boutonneuse fever group or its apparent group in Bangui (Central African Republic). Bull Soc Pathol Exot 1995; 88(3):126-128.
46. Williams WJ, Radulovic S, Dasch GA, et al. Identification of Rickettsia conorii infection by polymerase chain reaction in a soldier returning from Somalia. Clin Infect Dis 1994; 19:93-99.
47. Schroter G, Loose B, Trojan H. Serological studies on the occurrence of rickettsial infections in Togo (author’s transl). Trop Med Parasitol 1975; 26:323-328.
48. Tarasevich IV, Somov GP. Comparative serological study of tick-borne typhus in northern Asia and tsutsugamushi fever. J Microb Epidemiol Immunol 1966; 1:83-86.
49. Punda-Polic V, Klismanic Z, Capkun V, Bradaric N. Demographic and epidemiologic features of Mediterranean spotted fever cases in the region of split, Croatia. Ann NY Acad Sci 2003; 990:143-148.
50. Hemmersbach-Miller M, Parola P, Raoult D, Brouqui P. A homeless man with maculopapular rash who died in Marseille, France. Clin Infect Dis 2004; 38:1498-1499.
51. Renesto P, Dehoux P, Gouin E, Touqui L, Cossart P, Raoult D. Identification and characterization of a phospholipase D-superfamily gene in rickettsiae. J Infect Dis 2003; 188(9):1276-1283.
52. Walker DH, Valbuena GA, Olano JP. Pathogenic mechanisms of disease caused by Rickettsia. Ann NY Acad Sci 2001; 990:1-11.
53. Gouin E, Egile C, Dehoux P, et al. The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature 2004; 427(6973):457-461.
54. Gouin E, Gantelet H, Egile C, et al. A comparative study of the actin-based motilities of the pathogenic bacteria Listeria monocytogenes, Shigella flexneri and Rickettsia conorii. J Cell Sci 1999; 112:1697-1708.
55. Anton E, Font B, Munoz T, Sanfeliu I, Segura F. Clinical and laboratory characteristics of 144 patients with Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 2003; 22(2):126-128.
56. Raoult D, Weiller PJ, Chagnon A, Chaudet H, Gallais H, Casanova P. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg 1986; 35(4):845-850.
57. Martin Farfan A, Juarez Fernandez C, Calbo-Torrecillas F, Porras Ballesteros J, Diaz Recio M, Bermundez Recio F. Clinico-epidemiological study of 164 cases of boutonneuse fever. Rev Clin Esp 1985; 176:333-339.
58. Raoult D, Jean-Pastor MJ, Xeridat B, et al. Mediterranean boutonneuse fever: a propos of 154 recent cases. Ann Dermatol Venereol 1983; 110(11):909-914.
59. Garcia Miguel MJ, Garcia-Alix Perez A, de Jose Gomez MI, Barea Blanco I, Vidal Lopez ML, Garcia Hortelano J. Boutonneuse fever in children. An Esp Pediatr 1985; 22:353-358.
60. Moraga FA, Martinez-Roig A, Alonso JL, Boronat M, Domingo F. Boutonneuse fever. Arch Dis Child 1982; 57:149-151.
61. Cahuana A, Losada I, Galceran L, Lopez Casas JA, Pou J, Juncosa T. Mediterranean boutonneuse fever in children: study of 139 cases. An Esp Pediatr 1984; 21:642-647.
62. Cascio A, Dones P, Romano A, Titone L. Clinical and laboratory findings of boutonneuse fever in Sicilian children. Eur J Pediatr 1998; 157(6):482-486.
63. Cascio A, Colomba C, Antinori S, Paterson DL, Titone L. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis 2002; 34(2):154-158.
64. Font-Creus B, Espejo-Arenas E, Munoz-Espin T, Uriz-Urzainqui S, Bella-Cueto F, Segura-Porta F. Mediterranean boutonneuse fever: study of 246 cases. Med Clin (Barc) 1991; 96:121-125.
65. Font-Creus B, Bella-Cueto F, Espejo-Arenas E, et al. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis 1985; 7:635-642.
66. Fournier PE, Gouriet F, Brouqui P, Lucht F, Raoult D. Lymphangitis associated rickettsial diseases (LARD), a new rickettsiosis caused by Rickettsia sibirica mongolotimonae: seven new cases of and review of the literature. Clin Infect Dis 2004; 40(10):1435-1444.
67. Raoult D, Arnolds M, Garnier JM, de Micco P, Giraud E. Fievre boutonneuse mediterraneenne de l’enfant (à propos de 41 observations). Med Hyg 1983; 41:1013-1016.
68. Pedro Pons A. Fiebre exantematica mediterranea. Med Clin (Barc) 1945; 5:1-6.
69. Omezzine-Letaief A, Yacoub S, Tissot-Dupont H, et al. Seroepidemiological survey of rickettsial infections among blood donors in central Tunisia. Trans R Soc Trop Med Hyg 1995; 89:266-268.
70. Amaro M, Bacellar F, Franca A. Report of eight cases of fatal and severe Mediterranean spotted fever in Portugal. Ann NY Acad Sci 2003; 990:331-343.
71. Raoult D, Gallais H, Ottomani A, et al. Malignant form of Mediterranean boutonneuse fever: 6 cases. Presse Med 1983; 12:2375-2378.
72. Tavares L, Botas J, Antunes F, Araujo FC. A febre escaro-nodular em Portugal. O Médico 1986; 113:836-846.
73. Carmo G, Caixeiro IS, Uva AS, Paiva JED. Febre escaro-nodular actualizaçao teorica e analise retrospectiva de 231 casos. Rer Port Doenças Infecciosas 1981; 4:13-28.
74. Soriano V, Sabria M, Davins J, Manterola JM. Complications in Mediterranean boutonneuse fever: prospective study of 78 patients. Rev Clin Esp 1989; 184:459-463.
75. Valero A. Rocky Mountain spotted fever in Palestine. Harefuah 1949; 36:99.
76. Goldwasser RA, Klingberg MA, Klingberg W, Steiman Y, Swartz TA. Laboratory and epidemiologic studies of rickettsial sotted fever in Israel. 12th Int Congr Interm Med 1974; 270-275.
77. Sekeyova Z, Roux V, Raoult D. Phylogeny of Rickettsia spp. inferred by comparing sequences of ‘gene D’, which encodes an intracytoplasmic protein. Int J Syst Evol Microbiol 2001; 51(pt 4):1353-1360.
78. Fournier PE, Roux V, Raoult D. Phylogenetic analysis of spotted fever group rickettsiae by study of the outer surface protein rOmpA. Int J Syst Bacteriol 1998; 48:839-849.
79. Roux V, Rydkina E, Eremeeva M, Raoult D. Citrate synthase gene comparison, a new tool for phylogenetic analysis, and its application for the rickettsiae. Int J Syst Bacteriol 1997; 47:252-261.
80. Zhang JZ, Fan MY, Wu YM, Fournier PE, Roux V, Raoult D. Genetic classification of Rickettsia heilongjiangii and Rickettsia hulinii two Chinese spotted fever group rickettsiae. J Clin Microbiol 2000; 38(9):3498-3501.
81. Gross EM, Yagupsky P. Israeli rickettsial spotted fever in children: a review of 54 cases. Acta Trop 1987; 44(1):91-96.
82. Shazberg G, Moise J, Terespolsky N, Hurvitz H. Family outbreak of Rickettsia conorii infection. Emerg Infect Dis 1999; 5(5):723-724.
83. Regev-Yochay G, Segal E, Rubinstein E. Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever. Isr Med Assoc J 2000; 2(10):781-782.
84. Yagupsky P, Wolach B. Fatal Israeli spotted fever in children. Clin Infect Dis 1993; 17:850-853.
85. Bacellar F, Beati L, Franca A, Pocas J, Regnery R, Filipe A. Israeli spotted fever rickettsia (Rickettsia conorii complex) associated with human disease in Portugal. Emerg Infect Dis 1999; 5(6):835-836.
86. De Sousa R, Ismail N, Doria-Nobrega S, et al. The presence of eschars, but not greater severity, in Portuguese patients infected with Israeli spotted Fever. Ann NY Acad Sci 2005; 1063:197-202.
87. Giammanco G, Mansueto S, Ammatuna P, Vitale G. Israeli spotted fever Rickettsia in Sicilian Rhipicephalus sanguineus ticks. Emerg Infect Dis 2003; 9(7):892-893.
88. Tarasevich IV, Makarova VA, Fetisova NF, Stepanov AV, Miskarova ED, Raoult D. Studies of a “new” rickettsiosis “Astrakhan” spotted fever. Eur J Epidemiol 1991; 7:294-298.
89. Tarasevich IV, Makarova V, Fetisova NF, et al. Astrakhan fever: new spotted fever group rickettsiosis. Lancet 1991; 337:172-173.
90. Eremeeva M, Balayeva NM, Roux V, Ignatovich V, Kotsinjan M, Raoult D. Genomic and proteinic characterization of strain S, a Rickettsia isolated from Rhipicephalus sanguineus ticks in Armenia. J Clin Microbiol 1995; 33:2738-2744.
91. Eremeeva ME, Balayeva NM, Ignatovich VF, Raoult D. Proteinic and genomic identification of spotted fever group rickettsiae isolated in the former USSR. J Clin Microbiol 1993; 31(10):2625-2633.
92. Drancourt M, Beati L, Tarasevich IV, Raoult D. Astrakhan fever rickettsia is identical to Israeli tick typhus rickettsia, a genotype of the Rickettsia conorii complex. J Infect Dis 1992; 165:1167-1168.
93. Eremeeva ME, Beati L, Makarova VA, et al. Astrakhan fever rickettsiae: antigenic and genotypic of isolates obtained from human and Rhipicephalus pumilio ticks. Am J Trop Med Hyg 1994; 51(5):697-706.
94. Fournier PE, Durand JP, Rolain JM, Camicas JL, Tolou H, Raoult D. Detection of Astrakhan fever rickettsia from ticks in Kosovo. Ann NY Acad Sci 2003; 990:158-161.
95. Philip CB, Hughes LE, Rao KNA, Kalra SL. Studies of Indian tick typhus and its relation to other human typhus-like rickettsiosis. 5th International Congress for Microbiology, 1950.
96. Philip RN, Casper EA, Burgdorfer W, Gerloff RK, Hugues LE, Bell EJ. Serologic typing of rickettsiae of the spotted fever group by microimmunofluorescence. J Immunol 1978; 121:1961-1968.
97. Beati L, Finidori JP, Gilot B, Raoult D. Comparison of serologic typing, sodium dodecyl sulfatepolyacrylamide gel electrophoresis protein analysis, and genetic restriction fragment length polymorphism analysis for identification of rickettsiae: characterization of two new rickettsial strains. J Clin Microbiol 1992; 30:1922-1930.
98. Roux V, Raoult D. Phylogenetic analysis of members of the genus Rickettsia using the gene encoding the outer-membrane protein rOmpB (ompB). Int J Syst Evol Microbiol 2000; 50(pt 4):1449-1455.
99. Jayaseelan E, Rajendran SC, Shariff S, Fishbein D, Keystone JS. Cutaneous eruptions in Indian tick typhus. Int J Dermatol 1991; 30:790-794.
100. Mathai E, LLoyd G, Cherian T, Abraham OC, Cherian AM. Serological evidence for the continued presence of human rickettsioses in southern India. Ann Trop Med Parasitol 2001; 95(4):395-398.
101. Murali N, Pillai S, Cherian T, Raghupathy P, Padmini V, Mathai E. Rickettsial infections in South India-how to spot the spotted fever. Indian Pediatr 2001; 38(12):1393-1396.
102. Sundhindra BK, Vijayakumar S, Kutty KA, et al. Rickettsial spotted fever in Kerala. Natl Med J India 2004; 17(1):51-52.
103. Parola P, Miller RS, McDaniel P, et al. Emerging rickettsioses of the Thai-Myanmar border. Emerg Infect Dis 2003; 9(5):592-595.
104. Phongmany S, Rolain JM, Phetsouvanh R, et al. Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis 2006; 12(2):256-262.
105. Parola P, Fenollar F, Badiaga S, Brouqui P, Raoult D. First documentation of Rickettsia conorii infection (strain Indian tick typhus) in a traveller. Emerg Infect Dis 2001; 7(5):909-910.
106. Shaked Y, Samra Y, Maier MK, Rubinstein E. Relapse of rickettsial Mediterranean spotted fever and murine typhus after treatment with chloramphenicol. J Infect 1989; 18:35-37.
107. Munoz-Espin T, Lopez-Pares P, Espejo-Arenas E, et al. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch Dis Child 1986; 61(10):1027-1029.
108. Bella F, Font B, Uriz S, et al. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob Agents Chemother 1990; 34:937-938.
109. Segura F, Anton E. Clarithromycin for the treatment of Mediterranean spotted fever. Clin Infect Dis 2002; 34(4):560.
110. Raoult D, Gallais H, de Micco P, Casanova P. Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrob Agents Chemother 1986; 30:606-607.
111. Gudiol F, Pallares R, Carratala J, et al. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob Agents Chemother 1989; 33:987-988.
112. Ruiz Beltran R, Herrero-Herrero JI. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 1992; 11:427-431.
113. Raoult D, Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother 1991; 35(12):2457-2462.
114. Herrero-Herrero JI, Ruiz Beltran R, Martin Sanchez AM. Naturally acquired immunity: a means of resistance to Mediterranean spotted fever? J Infect Dis 1991; 164(3):618-619.
115. Ruiz Beltran R, Herrero-Herrero JI. Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever. Antimicrob Agents Chemother 1992; 36(6):1342-1344.
116. Bella F, Espejo-Arenas E, Uriz S, Serrano JA, Alegre MD, Tort J. Randomized trial of five-day rifampin versus one-day doxycycline therapy for Mediterranean spotted fever. J Infect Dis 1991; 164:433-434.
117. Yagupsky P, Gross EM, Alkan M, Bearman JE. Comparison of two dosage schedules of doxycycline in children with rickettsial spotted fever. J Infect Dis 1987; 155:1215-1219.
118. Bella-Cueto F, Font-Creus B, Segura-Porta F, Espejo-Arenas E, Lopez-Parez P, Munoz-Espin T. Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J Infect Dis 1987; 155:1056-1058.
119. Demartino G, Narciso P, Struglia C, Zechini F, Visco G. Therapeutic experience in the treatment of Rickettsia conorii infections with a single dose of doxycycline. Clin Ther 1981; 97:59-62.
120. Yebenes-Diaz G, Jimenez-Toboso J, Gonzalez-Barber A, Dorado-Pombo S. Mediterranean boutonneuse fever: effects of the duration of the treatment using doxycycline. Rev Clin Esp 1990; 186:309-310.
121. Meloni G, Meloni T. Azithromycin vs. doxycycline for Mediterranean spotted fever. Pediatr Infect Dis 2003; 15(11):1042-1044.